Release Summary

Millendo Therapeutics presents comprehensive clinical and preclinical summary of MLE4901 compound for polycystic ovary syndrome at Androgen Excess and Polycystic Ovary Syndrome Society Annual Meeting.

Millendo Therapeutics, Inc.